M.R. Cannavò

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Giuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso et al. · Journal of Hepatology · 2019 · 205 citations

Medicine, Infectious Diseases, Pharmacology +15

Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study

Giuseppe Cabibbo, Salvatore Petta, Vincenza Calvaruso et al. · Alimentary Pharmacology & Therapeutics · 2017 · 147 citations · Full text

Medicine, Oncology, Pharmacology +15

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

Daphne D’Amato, Antonio De Vincentis, Federica Malinverno et al. · JHEP Reports · 2021 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype

John P. Clancy, Samuel G. Johnson, Sook Wah Yee et al. · Clinical Pharmacology & Therapeutics · 2014 · 77 citations · Full text

Medicine, Genetics, Pharmacology +15

Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Giuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso et al. · Digestive and Liver Disease · 2019 · 15 citations

Medicine, Infectious Diseases, Pharmacology +12